Xoma Royalty share price today

(XOMA)

Xoma Royalty share price is $27.13 & ₹2,305.40 as on 21 Dec 2024, 2.30 'hrs' IST

$27.13

▲

2.02

(8.04%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Xoma Royalty share price in Dollar and Rupees. Guide to invest in Xoma Royalty from India. Also see the sentimental analysis on Indian investors investing in Xoma Royalty. Get details on the Indian mutual funds that are investing in Xoma Royalty. Get Analyst recommendations and forecasts along with all the Xoma Royalty's financials.

Xoma Royalty share price movements

Today's Low: $24.74
Today's High: $27.48
$27.13
8.81%
Downside
Day's Volatility :9.97%
Upside
1.27%
52 Weeks Low: $17.80
52 Weeks High: $35.00
$27.13
34.39%
Downside
52 Weeks Volatility :49.14%
Upside
22.49%

Xoma Royalty Returns

Period	Xoma Royalty Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	0.15%	-11.1%	0.0%
6 Months	5.03%	-6.0%	0.0%
1 Year	47.45%	2.7%	0.0%
3 Years	20.69%	0.6%	-19.7%

Xoma Royalty Key Statistics

in dollars & INR

Previous Close	$25.11
Open	$24.88
Today's High	$27.48
Today's Low	$24.74
Market Capitalization	$295.9M
Today's Volume	$129.0K
52 Week High	$35.0
52 Week Low	$17.8
Revenue TTM	$21.6M
EBITDA	$-15.2M
Earnings Per Share (EPS)	$-3.07
Profit Margin	-138.67%
Quarterly Earnings Growth YOY	0.37%
Return On Equity TTM	-31.41%

How to invest in Xoma Royalty from India?

It is very easy for Indian residents to invest directly in Xoma Royalty from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xoma Royalty stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xoma Royalty or XOMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xoma Royalty or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xoma Royalty shares which would translate to 0.031 fractional shares of Xoma Royalty as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Xoma Royalty, in just a few clicks!

Returns in Xoma Royalty for Indian investors in Rupees

Investment Value

₹1,00,000

Xoma Royalty investment value today

Current value as on today

₹1,49,642

Returns

₹49,642

(+49.64%)

Returns from Xoma Royalty Stock

₹47,446 (+47.45%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Xoma Royalty

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Xoma Royalty on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 0% more investors are searching Xoma Royalty in the last 30 days versus the previous period.

Global Institutional Holdings in Xoma Royalty

Bvf Inc
30.84%
FMR Inc
9.36%
BlackRock Inc
4.35%
Vanguard Group Inc
3.58%
Opaleye Management Inc
2.12%
Stonepine Capital Management Llc
1.66%

Analyst Recommendation on Xoma Royalty

Buy

77%Buy

22%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Xoma Royalty(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Xoma Royalty

What analysts predicted

Upside of 228.05%

Current:

$27.13

Target:

$89.00

Insights on Xoma Royalty

Price Movement
In the last 1 year, XOMA stock has moved up by 50.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 11.08M → 7.19M (in $), with an average decrease of 35.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 15.98M → -17.24M (in $), with an average decrease of 207.9% per quarter
XOMA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 2.7%

Xoma Royalty Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.3M	↓ 89.94%
Net Income	$-13.3M	↓ 191.42%
Net Profit Margin	-251.8%	↓ 279.5%

	FY19	Y/Y Change
Revenue	$18.4M	↑ 246.67%
Net Income	$-7.7M	↓ 42.31%
Net Profit Margin	-41.91%	↑ 209.89%

	FY20	Y/Y Change
Revenue	$29.4M	↑ 59.96%
Net Income	$13.3M	↓ 272.75%
Net Profit Margin	45.25%	↑ 87.16%

	FY21	Y/Y Change
Revenue	$38.2M	↑ 29.86%
Net Income	$15.8M	↑ 18.8%
Net Profit Margin	41.4%	↓ 3.85%

	FY22	Y/Y Change
Revenue	$6.0M	↓ 84.21%
Net Income	$-17.1M	↓ 208.27%
Net Profit Margin	-283.79%	↓ 325.19%

	FY23	Y/Y Change
Revenue	$4.8M	↓ 21.06%
Net Income	$-40.8M	↑ 138.72%
Net Profit Margin	-858.15%	↓ 574.36%

	Q2 FY23	Q/Q Change
Revenue	$1.7M	↑ 279.41%
Net Income	$-5.4M	↓ 69.53%
Net Profit Margin	-325.69%	↑ 3729.23%

	Q3 FY23	Q/Q Change
Revenue	$830.0K	↓ 49.94%
Net Income	$-5.5M	↑ 2.02%
Net Profit Margin	-663.73%	↓ 338.04%

	Q4 FY23	Q/Q Change
Revenue	$1.8M	↑ 120.84%
Net Income	$-20.1M	↑ 265.02%
Net Profit Margin	-1.1K%	↓ 433.32%

	Q1 FY24	Q/Q Change
Revenue	$1.5M	↓ 18.71%
Net Income	$-8.6M	↓ 57.26%
Net Profit Margin	-576.85%	↑ 520.2%

	Q2 FY24	Q/Q Change
Revenue	$11.1M	↑ 644.03%
Net Income	$16.0M	↓ 285.98%
Net Profit Margin	144.19%	↑ 721.04%

	Q3 FY24	Q/Q Change
Revenue	$7.2M	↓ 35.08%
Net Income	$-17.2M	↓ 207.87%
Net Profit Margin	-239.59%	↓ 383.78%

	FY18	Y/Y Change
Profit	$3.6M	↓ 91.93%

	FY19	Y/Y Change
Profit	$17.1M	↑ 373.24%

	FY20	Y/Y Change
Profit	$29.2M	↑ 70.68%

	FY21	Y/Y Change
Profit	$38.0M	↑ 30.03%

	FY22	Y/Y Change
Profit	$5.9M	↓ 84.39%

	FY23	Y/Y Change
Profit	$3.9M	↓ 34.89%

	Q2 FY23	Q/Q Change
Profit	$1.4M	↑ 576.42%

	Q3 FY23	Q/Q Change
Profit	$606.0K	↓ 57.74%

	Q4 FY23	Q/Q Change
Profit	$1.6M	↑ 165.35%

	Q1 FY24	Q/Q Change
Profit	$1.5M	↓ 7.46%

	Q2 FY24	Q/Q Change
Profit	$11.1M	↑ 644.83%

	Q3 FY24	Q/Q Change
Profit	$7.2M	↓ 35.06%

	FY18	Y/Y Change
Operating Cash Flow	$-12.6M	↓ 570.74%
Investing Cash Flow	$-15.0M	↓ 1034.37%
Financing Cash Flow	$29.9M	↑ 125.82%

	FY19	Y/Y Change
Operating Cash Flow	$-285.0K	↓ 97.75%
Investing Cash Flow	$-19.3M	↑ 28.62%
Financing Cash Flow	$30.5M	↑ 1.85%

	FY20	Y/Y Change
Operating Cash Flow	$10.1M	↓ 3641.05%
Investing Cash Flow	$-209.0K	↓ 98.92%
Financing Cash Flow	$19.8M	↓ 35.09%

	FY21	Y/Y Change
Operating Cash Flow	$22.7M	↑ 124.71%
Investing Cash Flow	$-26.5M	↑ 12579.43%
Financing Cash Flow	$12.8M	↓ 35.15%

	FY22	Y/Y Change
Operating Cash Flow	$-12.9M	↓ 156.79%
Investing Cash Flow	$-20.2M	↓ 23.69%
Financing Cash Flow	$-4.5M	↓ 134.68%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.2M	↑ 46.39%
Investing Cash Flow	$-4.5M	↓ 38.04%
Financing Cash Flow	$-1.2M	↓ 14.84%

Xoma Royalty Technicals Summary

Sell

Neutral

Buy

Xoma Royalty is currently in a neutral trading position according to technical analysis indicators.

Xoma Royalty Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Xoma Royalty Corp	-9.78%	5.03%	47.45%	20.69%	-2.34%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Xoma Royalty Corp	24.2	NA	-0.42	-1.13	-0.31	-0.06	NA	7.21
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Xoma Royalty Corp	Buy	$295.9M	-2.34%	24.2	-138.67%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Xoma Royalty

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com.

Organization	Xoma Royalty
Employees	13
CEO	Mr. Owen P. Hughes Jr.
Industry	Health Technology

Management People of Xoma Royalty

Name	Title
Mr. Owen P. Hughes Jr.	CEO & Director
Mr. Thomas M. Burns	Senior VP of Finance & CFO
Mr. Brad Sitko	Chief Investment Officer

Important FAQs about investing in Xoma Royalty from India :

What is Xoma Royalty share price today?

Xoma Royalty share price today stands at $27.13, Open: $24.88 ; Previous Close: $25.11 ; High: $27.48 ; Low: $24.74 ; 52 Week High: $35.00 ; 52 Week Low: $17.80. The stock opens at $24.88, after a previous close of $25.11. The stock reached a daily high of $27.48 and a low of $24.74, with a 52-week high of $35.00 and a 52-week low of $17.80.

Can Indians buy Xoma Royalty shares?

Yes, Indians can invest in the Xoma Royalty (XOMA) from India.

With INDmoney, you can buy Xoma Royalty at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Xoma Royalty at zero transaction cost.

How can I buy Xoma Royalty shares from India?

It is very easy to buy Xoma Royalty from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xoma Royalty be purchased?

Yes, you can buy fractional shares of Xoma Royalty with INDmoney app.

What are the documents required to start investing in Xoma Royalty stocks?

To start investing in Xoma Royalty, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.